CN103784946B - A kind of pharmaceutical composition treating condyloma acuminatum - Google Patents

A kind of pharmaceutical composition treating condyloma acuminatum Download PDF

Info

Publication number
CN103784946B
CN103784946B CN201410056312.4A CN201410056312A CN103784946B CN 103784946 B CN103784946 B CN 103784946B CN 201410056312 A CN201410056312 A CN 201410056312A CN 103784946 B CN103784946 B CN 103784946B
Authority
CN
China
Prior art keywords
herba
radix
pharmaceutical composition
condyloma acuminatum
stone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410056312.4A
Other languages
Chinese (zh)
Other versions
CN103784946A (en
Inventor
王海英
郑振杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410056312.4A priority Critical patent/CN103784946B/en
Publication of CN103784946A publication Critical patent/CN103784946A/en
Application granted granted Critical
Publication of CN103784946B publication Critical patent/CN103784946B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times. Useful effect of Chinese medicine of the present invention is: heat-clearing and toxic substances removing, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, can thoroughly remove the virus under local skin mucosa while dispelling body surface wart body, improves immunity, systematic treating, reaches thorough radical cure and do not recur.

Description

A kind of pharmaceutical composition treating condyloma acuminatum
Technical field
The present invention relates to a kind of pharmaceutical composition treating condyloma acuminatum.
Background technology
Condyloma acuminatum is to be infected the caused sexually transmitted disease (STD) being main manifestations with anus genital area hyperplastic lesions by human papillomavirus (HPV). Mostly betide the young people of 18��50 years old. Approximately pass through two weeks to 8 months, average out to sequela incubation period of 3 months. This disease is relatively conventional, mainly through transmission through sex. The HPV the most often causing condyloma acuminatum has 6,11 etc. HPV is easy survival and reproduction when human body warm moist, therefore external genitalia and crissum are the positions being easiest to infect.
Summary of the invention
Useful effect of Chinese medicine of the present invention is: heat-clearing and toxic substances removing, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, can thoroughly remove the virus under local skin mucosa while removing body surface wart body, improves immunity, systematic treating, reaches thorough radical cure and do not recur.
The technical problem to be solved is to overcome technical deficiency, it is provided that a kind of good effect, short treating period, remission rate is high, and cost is low, a kind of pharmaceutical composition treating condyloma acuminatum having no side effect.
For above-mentioned purpose, a kind of pharmaceutical composition treating condyloma acuminatum, it is characterized in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g, above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Radix Salviae Miltiorrhizae bitter in the mouth in Chinese medicine of the present invention, feeble QI is trembled with fear, nontoxic. Enter the heart, spleen two warp. Promoting blood circulation to restore menstrual flow, evacuation of pus granulation promoting, special regulating menstruation arteries and veins, reason iliacus is ached, and tissue regeneration promoting blood removes stagnant blood. " book on Chinese herbal medicine is looked for the truth ": Radix Salviae Miltiorrhizae, book load can enter percardium removing blood stasis with potent drugs one language, has use up Radix Salviae Miltiorrhizae effect. So have opinion its can tissue regeneration promoting antiabortive, regulating menstruation relieving restlessness, sedate of reposing, and all migratory arthralgia, metrorrhagia and leukorrhagia, lump in the abdomen, conjunctival congestion, colic, skin ulcer scabies the disease such as swell and ache. Semen Ricini belongs to the seed of euphorbia plant Semen Ricini, and function cures mainly: detumescence and drawing out poison;Rush down lower intestinal stasis relieving; Dredging collateral profit key. Main swollen ulcer drug; Scrofula, acute mastitis, sore throat, mange tinea skin ulcer, scald, edema distension, traumatic injury. Squama Manis salty in the mouth, cold nature. Return liver, stomach warp. Function with cure mainly: the abdominal mass that disappears of invigorating blood circulation, stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, search wind and removing obstruction in channels. For carbuncle sore tumefacting virus, rheumatic arthralgia .... It is prepared that Matrii Sulfas Exsiccatus is that Natrii Sulfas dries through air slaking. Main sulfur acid sodium. Function with cure mainly: relieving constipation by purgation, moistening for dryness and softening hard mass, detumescence of relieving inflammation or internal heat. External treatment laryngopharynx swelling and pain, aphtha of the mouth and tongue, gingival swelling and pain, conjunctival congestion, carbuncle, erysipelas. Spend stone sour in the mouth of heap of stone, puckery, property put down. Return Liver Channel. Merit Bears with cure mainly: removing stasis to stop bleeding. Fructus Gardeniae heat clearing away, pathogenic fire purging, removing heat from blood. Modern study, has antibacterial, antiinflammatory and the effect for the treatment of soft tissue injury. Herba Hyperici Japonici is the herb of Garcinia maingayii Herba Hyperici Japonici. Clearing away heat-damp and promoting diuresis, removing toxic substances, dissipating blood stasis for subsidence of swelling. Main jaundice due to damp-heat; Carbuncle furuncle and phyma poison, tonsillitis, aphtha, conjunctival congestion and swelling pain, venom, traumatic injury. Bacteriostasis: in vitro tests, Common Pathogenic fungus is had obvious inhibiting effect by Herba Hyperici Japonici decoct. Herba Artemisiae Anomalae this product is the dry herb of goatweed Herba Siphonostegiae. Function with cure mainly: blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia, removing heat from blood, hemostasis, clearing away heat-damp and promoting diuresis. Radix Paeoniae Rubra bitter in the mouth, cold in nature. Return spleen, stomach, liver, gallbladder meridian. Function cures mainly: clots absorbing, pain relieving, removing heat from blood, detumescence. For maculae caused by violent heat pathogen, injury from falling down, carbuncle skin infection .... Herba pterocephali this product is Dipsacaceae plant spoon leaf Herba pterocephali. Function with cure mainly: removing toxic substances is except pestilence, and dispel the wind blood stasis dispelling. Oleum Radix Arnebiae (Oleum Radix Lithospermi) has effect of box set, convergence. Above compatibility of drugs, bring out the best in each other.
The present invention follows the prescription principle of the traditional Chinese medical science, and be decocted in water for oral dose use, through clinical application for many years verify, total effective rate 96.7%, cure rate 83.8%, have no side effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1: a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g. By all levigation end is standby above. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Embodiment 2: a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 9g, Semen Ricini 12g, Squama Manis 3g, Matrii Sulfas Exsiccatus 4g, spend stone 4g of heap of stone, Fructus Gardeniae 9g, Herba Hyperici Japonici 6g, Herba Artemisiae Anomalae 6g, Radix Paeoniae Rubra 6g, Herba pterocephali 2g. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well deposited affected part, every day 2 times, each 30 minutes. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Clinical efficacy is summed up:
One, physical data: we are extensive in clinical practice for many years, treat female patient 66 example, the age at 31��56 years old, average 39.2 years old. Curative effect frequency is good. It is not taken by pregnant women.
Two, diagnostic criteria: sexual contact history or mediate contact infect history, typical case's skin lesion is that the moist position such as genitals or crissum pimple, mamillary, cauliflower form or cockscomb shape meat vegetation, rough surface keratinization occurs. 2. auxiliary examination: Acetic acid test is positive, and nucleic acid hybridization can detect HPV-DNA correlated series, PCR detects visible specificity HPV-DNA and expands zone etc.3. patient has unclean sexual life history or spouse to infect history more, and minority condyloma acuminatum is infected by the apparatus of contact stain, and it is infected that neonate also can pass through birth canal. 1��8 month incubation period not etc., average out to 3 months.
Three, method of administration: above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. , adult every day 1 dose, every dose of pan-fried 200ml, early, evening sub-service, every 10 days was 1 course for the treatment of. Interferon injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times.
Four, curative effect judging standard
Cure: clinical symptoms is wholly absent.
Take a turn for the better: clinical symptoms is improved.
Invalid: clinical symptoms is unchanged or increases the weight of.
Five, therapeutic effect: the present invention, for many years in clinical practice, treats 66 example patients, cures 52 examples 83.8%, and take a turn for the better 9 examples, is 12.9%; Invalid 1 example. Total effective rate 96.7%, cure rate 83.8%.
Six, model case
1, Rhizoma Zingiberis Recens ����, female, 32 years old, in June, 2010 went to a doctor. Skin lesion, perineum and crissum mamillary meat vegetation, rough surface keratinization 2 months occur under main suit's breast. Lab testing: Acetic acid test is positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.
2, Lee's ����, female, 39 years old, in JIUYUE, 20110 was gone to a doctor, and main suit has spouse to infect history, and skin lesion, mamillary meat vegetation, rough surface keratinization 2 months occurs in crissum. Lab testing: the acetic acid white experiment positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.
3, high ��, man, 22 years old, in November, 2012 went to a doctor. There is skin lesion, mamillary meat vegetation, rough surface keratinization 2 months in main suit's crissum. Lab testing: Acetic acid test is positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.

Claims (1)

1. the pharmaceutical composition treating condyloma acuminatum, it is characterized in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, Ophicalcitum 4��6g, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g, above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby.
CN201410056312.4A 2014-02-16 2014-02-16 A kind of pharmaceutical composition treating condyloma acuminatum Expired - Fee Related CN103784946B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410056312.4A CN103784946B (en) 2014-02-16 2014-02-16 A kind of pharmaceutical composition treating condyloma acuminatum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410056312.4A CN103784946B (en) 2014-02-16 2014-02-16 A kind of pharmaceutical composition treating condyloma acuminatum

Publications (2)

Publication Number Publication Date
CN103784946A CN103784946A (en) 2014-05-14
CN103784946B true CN103784946B (en) 2016-06-08

Family

ID=50661281

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410056312.4A Expired - Fee Related CN103784946B (en) 2014-02-16 2014-02-16 A kind of pharmaceutical composition treating condyloma acuminatum

Country Status (1)

Country Link
CN (1) CN103784946B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1418685A (en) * 2002-11-29 2003-05-21 张慧芳 Medicine composition for treating and its prepn. method
CN1915348A (en) * 2006-08-17 2007-02-21 胡国良 Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method
CN102366567A (en) * 2011-10-12 2012-03-07 王世勋 Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1418685A (en) * 2002-11-29 2003-05-21 张慧芳 Medicine composition for treating and its prepn. method
CN1915348A (en) * 2006-08-17 2007-02-21 胡国良 Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method
CN102366567A (en) * 2011-10-12 2012-03-07 王世勋 Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"中西医结合治疗尖锐湿疣62例";汪玉梅;《中国医学文摘-皮肤科学》;20100430;第27卷(第2期);第77-78页 *

Also Published As

Publication number Publication date
CN103784946A (en) 2014-05-14

Similar Documents

Publication Publication Date Title
CN102755426B (en) Chinese medicament for treating gynecological inflammation and preparation method
CN101085271B (en) Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease
CN104189871A (en) Medicated wine for treating osteoproliferation
CN101129868A (en) Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease
CN104721749A (en) Traditional Chinese medicine cleaning solution for treating puerperal infection and preparation method of traditional Chinese medicine cleaning solution
CN103908600B (en) The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method
CN103007093A (en) Medicine for treating gynecological inflammation and preparation method thereof
CN102764360B (en) Traditional Chinese medicine composition for treating acute cystitis
CN105362839A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN102772699B (en) Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease
CN104825921A (en) External-use traditional Chinese medicine for treating eczema
CN104147252A (en) Traditional Chinese medicine preparation for treating hepatitis
CN103784946B (en) A kind of pharmaceutical composition treating condyloma acuminatum
CN103784806B (en) A kind of Chinese medicine treating anemopyretic urticaria
CN102949467A (en) Medicinal composition for treating chronic pelvic inflammation caused by dampness and hotness obstruction
CN103933429A (en) Traditional Chinese medicine composition for treating vaginitis
CN104398613A (en) Traditional Chinese medicine for treating hemorrhoid
CN104189477A (en) Traditional Chinese medicine formula for treating barbiers
CN104274617A (en) Traditional Chinese medicine composition for nursing treatment of acute cervicitis
CN102688456B (en) Chinese medicinal composition for treating chronic prostatitis
CN103285177A (en) Externally used paste for treating bedsore and furuncle
CN105999033A (en) Traditional Chinese medicine composition for nursing chronic rhinitis
CN103933390B (en) Traditional Chinese medicinal preparation for treating breast cystic hyperplasia
CN104740528B (en) A kind of traditional Chinese medicine powder for treating cervicitis
CN104147408A (en) External traditional Chinese medicament for treating hyperostosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160608

Termination date: 20220216

CF01 Termination of patent right due to non-payment of annual fee